These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32779840)

  • 1. COVID-19 in pediatric cancer patients in a resource-limited setting: National data from Peru.
    Montoya J; Ugaz C; Alarcon S; Maradiegue E; García J; Díaz R; Zapata A; Chávez S; Morales R; Ordoñez K; Hernandez E; Reaño R; Gutierrez C; Vargas MP; Sanchez K; Valdiviezo C; Maza I; Rojas N; Moore C; León E; Vásquez L
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28610. PubMed ID: 32779840
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico.
    Lima-Morales R; Méndez-Hernández P; Flores YN; Osorno-Romero P; Sancho-Hernández CR; Cuecuecha-Rugerio E; Nava-Zamora A; Hernández-Galdamez DR; Romo-Dueñas DK; Salmerón J
    Int J Infect Dis; 2021 Apr; 105():598-605. PubMed ID: 33578014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trends in drugs usage for COVID-19 during the first wave of the pandemic in a hospital in Lima, Peru].
    Castro NE; García DR; Rivera MT; Rondán-Guerrero P; García-Rojas F; Taype-Rondan A
    Rev Peru Med Exp Salud Publica; 2021; 38(4):608-614. PubMed ID: 35385014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pandemic and promise: progress towards finding an effective treatment for Novel Coronavirus 19.
    Merone L; Finlay S
    Aust N Z J Public Health; 2020 Dec; 44(6):437-439. PubMed ID: 33044799
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
    Okumuş N; Demirtürk N; Çetinkaya RA; Güner R; Avcı İY; Orhan S; Konya P; Şaylan B; Karalezli A; Yamanel L; Kayaaslan B; Yılmaz G; Savaşçı Ü; Eser F; Taşkın G
    BMC Infect Dis; 2021 May; 21(1):411. PubMed ID: 33947344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.
    Fiolet T; Guihur A; Rebeaud ME; Mulot M; Peiffer-Smadja N; Mahamat-Saleh Y
    Clin Microbiol Infect; 2021 Jan; 27(1):138-140. PubMed ID: 33080383
    [No Abstract]   [Full Text] [Related]  

  • 8. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings.
    Jimenez-Cauhe J; Ortega-Quijano D; Carretero-Barrio I; Suarez-Valle A; Saceda-Corralo D; Moreno-Garcia Del Real C; Fernandez-Nieto D
    Clin Exp Dermatol; 2020 Oct; 45(7):892-895. PubMed ID: 32385858
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral and Anti-Inflammatory Properties of Ivermectin and Its Potential Use in COVID-19.
    Portmann-Baracco A; Bryce-Alberti M; Accinelli RA
    Arch Bronconeumol (Engl Ed); 2020 Dec; 56(12):831. PubMed ID: 32736876
    [No Abstract]   [Full Text] [Related]  

  • 11. Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load.
    Nguyen TV
    Int J Antimicrob Agents; 2021 Jan; 57(1):106169. PubMed ID: 33408026
    [No Abstract]   [Full Text] [Related]  

  • 12. Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19.
    Khan MSI; Khan MSI; Debnath CR; Nath PN; Mahtab MA; Nabeka H; Matsuda S; Akbar SMF
    Arch Bronconeumol (Engl Ed); 2020 Dec; 56(12):828-830. PubMed ID: 33293006
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 in Still's disease.
    de Carvalho JF
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12627-12629. PubMed ID: 33378008
    [No Abstract]   [Full Text] [Related]  

  • 14. Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.
    Mori N; Katayama M; Nukaga S
    J Microbiol Immunol Infect; 2021 Feb; 54(1):109-112. PubMed ID: 33054978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19.
    Colson P; La Scola B; Lagier JC; Gautret P; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106238. PubMed ID: 33408030
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
    Goldman JD; Diaz G; Urba WJ
    Int J Antimicrob Agents; 2021 Jan; 57(1):106174. PubMed ID: 33408020
    [No Abstract]   [Full Text] [Related]  

  • 17. Doxycycline as an Alternative to Azithromycin in Elderly Patients.
    Malek AE; Granwehr BP
    Int J Antimicrob Agents; 2021 Jan; 57(1):106168. PubMed ID: 33408018
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
    Million M; Roussel Y; Gautret P; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106240. PubMed ID: 33408019
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.
    Prats-Uribe A; Sena AG; Lai LYH; Ahmed WU; Alghoul H; Alser O; Alshammari TM; Areia C; Carter W; Casajust P; Dawoud D; Golozar A; Jonnagaddala J; Mehta PP; Gong M; Morales DR; Nyberg F; Posada JD; Recalde M; Roel E; Shah K; Shah NH; Schilling LM; Subbian V; Vizcaya D; Zhang L; Zhang Y; Zhu H; Liu L; Cho J; Lynch KE; Matheny ME; You SC; Rijnbeek PR; Hripcsak G; Lane JC; Burn E; Reich C; Suchard MA; Duarte-Salles T; Kostka K; Ryan PB; Prieto-Alhambra D
    BMJ; 2021 May; 373():n1038. PubMed ID: 33975825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivermectin: an award-winning drug with expected antiviral activity against COVID-19.
    Formiga FR; Leblanc R; de Souza Rebouças J; Farias LP; de Oliveira RN; Pena L
    J Control Release; 2021 Jan; 329():758-761. PubMed ID: 33038449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.